Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,414 | -9,451 | -41,830 | -34,534 | -27,429 |
| Depreciation Amortization | 116 | 63 | 1,715 | 1,645 | 1,384 |
| Other Working Capital | 313 | -825 | -10,689 | -17,528 | -6,531 |
| Other Operating Activity | 1,904 | 958 | 14,093 | 12,498 | 5,694 |
| Operating Cash Flow | $-14,081 | $-9,255 | $-36,711 | $-37,919 | $-26,882 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,046 | 5,786 | -4,985 | -3,987 | 18,000 |
| PPE Investments | N/A | N/A | 707 | -26 | N/A |
| Investing Cash Flow | $23,046 | $5,786 | $-4,278 | $-4,013 | $18,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -292 | -292 | -218 |
| Common Stock Issued | 9,593 | 3,437 | 146 | 62 | 70 |
| Other Financing Activity | -4,000 | -4,000 | 0 | 0 | 0 |
| Financing Cash Flow | $5,593 | $-563 | $-146 | $-230 | $-148 |
| Beginning Cash Position | 34,607 | 34,607 | 75,742 | 75,742 | 75,742 |
| End Cash Position | 49,165 | 30,575 | 34,607 | 33,580 | 66,712 |
| Net Cash Flow | $14,558 | $-4,032 | $-41,135 | $-42,162 | $-9,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,081 | -9,255 | -36,711 | -37,919 | -26,882 |
| Capital Expenditure | N/A | N/A | -43 | -26 | N/A |
| Free Cash Flow | -14,081 | -9,255 | -36,754 | -37,945 | -26,882 |